Hong Kong Study Using Valsartan in IgA Nephropathy (HKVIN): A Double-Blind, Randomized, Placebo-Controlled Study
Top Cited Papers
- 1 May 2006
- journal article
- research article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 47 (5) , 751-760
- https://doi.org/10.1053/j.ajkd.2006.01.017
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Blood Pressure Control, Drug Therapy, and Kidney DiseaseHypertension, 2005
- Treatment of primary IgA nephropathyKidney International, 2004
- The effects of dual blockade of the renin- angiotensin system on urinary protein and transforming growth factor-b excretion in 2 groups of patients with IgA and diabetic nephropathyClinical Nephrology, 2003
- Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathiesKidney International, 2003
- Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonistsKidney International, 2000
- Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuriaThe Lancet, 1999
- A randomized prospective comparison of nadolol, captopril with or without ticlopidine on disease progression in IgA nephropathyNephrology, 1998
- Fish Oil for IgA Nephropathy?New England Journal of Medicine, 1994
- A Controlled Trial of Fish Oil in IgA NephropathyNew England Journal of Medicine, 1994
- Deterioration of GFR in IgA nephropathy as measured by 51Cr-EDTA clearanceKidney International, 1991